Solventum Corp. (SOLV)
BMV
Closed
Aug 21, 2026
Day's Range
1,382.0052 wk Range
1,273.00Overview - SOLV - Solventum Corp.
Key Statistics
Valuation
Enterprise Value
4.05T
P/E (Trailing)
‪9.97‬
PEG Ratio
‪5.18‬
Price / Sales (TTM)
‪28.30‬
Price / Book
‪2.88‬
EV / EBITDA
‪210.83‬
Profitability
Gross Margin
‪58.21%‬
Profit Margin
‪17.25%‬
Operating Margin
‪9.77%‬
Return on Assets
‪2.69%‬
Return on Equity
‪33.96%‬
Ownership
Shares Outstanding
170.11M
Float
144.13M
Held by Insiders
‪15.31%‬
Held by Institutions
‪76.01%‬
Price stats
Beta
‪0.67‬
50-Day Avg
‪1,369.00‬
200-Day Avg
‪1,400.66‬
Dividends
Payout Ratio
‪0.00%‬
Shariah Compliance
Report Date: Feb 17, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - SOLV - Solventum Corp.
Peers - SOLV - Solventum Corp.
Peer Comparison
Compared with companies in Medical Instruments & Supplies listed on BMV.
Profile Summary - SOLV - Solventum Corp.
About
Solventum Corporation is a healthcare company that develops, manufactures, and commercializes solutions leveraging material science, data science, and digital capabilities to address customer and patient needs. It operates through three primary segments: MedSurg, which provides wound therapy, I.V. site management,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
